Trisalus (TLSI) 2026 Earnings Outlook for Investors
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
76 articles
Karyopharm (KPTI) 2026 Earnings: Outlook and Strategy
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
Allogene (ALLO) 2026 Earnings Outlook for Investors
This guide breaks down what to watch in allogene (allo) 2026 earnings. Learn how pipeline progress, cash runway, and ...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Ligand (LGND) 2026 Earnings Outlook for Investors
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Abcellera (ABCL) 2026 Earnings Outlook for Investors
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
Capricor's Insider Just Sold: Read the Signals for Investors
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Structure Therapeutics Stock 47% Jump: What It Means
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
PacBio (PACB) 2026 Earnings: Insights & Investment Outlook
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
BridgeBio (BBIO) 2026 Earnings: Practical Investor Guide
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Related Topics
#Earnings Analysis (17)
#Stock Analysis (14)
#Portfolio Management (14)
#Stock Market (10)
#Investing (8)
#Portfolio Strategy (7)
#risk-management (6)
#Hedge Funds (5)
#Investment Strategy (4)
#Earnings (4)
#SEC Filings (4)
#Healthcare Stocks (3)
#portfolio-allocation (3)
#Stock Market News (3)
#Insider Trading (3)